期刊文献+

16-妊娠双烯醇酮阴道栓的制备与质量控制

Preparation and quality control of 16-dehydropregnenolone vaginal suppository
原文传递
导出
摘要 目的:制备16-妊娠双烯醇酮(16-DHP)阴道栓并建立其质量控制方法。方法:以S-40和PEG 400为基质制备16-DHP阴道栓;以紫外分光光度法测定其溶出度和含量,并初步考察其稳定性。结果:所制栓剂为白色子弹型栓剂,软硬度合适;鉴别、检查等符合中国药典2010年版相应规定;溶出度为95%,含量测定线性范围为5.0-25.0μg·ml-1(r=0.999 6),低、中、高浓度平均回收率范围为99.1%-101.2%;初步稳定性试验结果显示各指标无明显变化。结论:该制剂制备工艺简便可行,质量稳定可控。 OBJECTIVE To prepare 16-dehydropregnenolone (DHP) vaginal suppository and establish corresponding quality control standards. METHODS 16-DHP suppository was prepared with PEG 400 and S-40 as base materials and 16-DHP as the ingredient. The dissolution rate and content of 16-DHP in the suppository were determined by UV spectrophotometry, and its stability was preliminarily observed. RESULTS The suppository was white and bullet-shaped, with proper hardness. The identification and tests were in line with the standards stated in Chinese Pharmacopeia (2010 edition). The accumulative dissolution rate was 95 %, linear range of 16-DHP content was 5 - 25 μg · ml^-1 (r = 0. 9996), with average recovery rate between 99. 1 % and 101.2% at low, moderate and high concentrations. The preliminary stability test showed no significant changes of different parameters. CONCLUSION The preparation process of suppository is simple and feasible, with stable and controlla- ble quality.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第1期27-31,共5页 Chinese Journal of Hospital Pharmacy
基金 沈阳市科技局项目(编号:F11-148-9-00) 辽宁省教育厅创新团队项目(编号:LT2012018)
关键词 16-妊娠双烯醇酮 阴道栓 制备 质量控制 紫外分光光度法 16-dehydropregnenolone vaginal suppository preparation quality control UV spectrophotometry
  • 相关文献

参考文献15

  • 1Sun LX, Fu WW, Ren J,et al. Cytotoxic constituents from solanum lyratum[J]. Arch Pharm Res, 2006, 29(2): 135-139.
  • 2Ma EL, Zhao DM, Li YC, et al. Activation of ATM-Chk2 by 16-dehydropregnenolone induces G1 phase arrest andapoptosisin HeLa cells[J]. J Asian Nat Prod Res, 2012, 14 (9): 817-825.
  • 3Pratap R. Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones[P]. Erfinder:Gupta RC, Chander R, Khanna AK. IN. US. Cl: 514/169. US 6579862 B1, 2003-06-17.
  • 4Satyendra S, Wahajuddin, Gupta RC, et al. Preclinical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropregnenolone, an antihyperlipidemic agent, in rats[J]. J Pharm Pharmacol, 2011, 63(1): 41-48.
  • 5中国药典.二部[S].2010:707.
  • 6Eckstein P, Jackson MC, Millman N, et al. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and moneys[J]. J Reproduc Fertil, 1969, 20(1): 85.
  • 7谢沐风.溶出度实验、测定方法验证[J].实验与分析,2009(6):20-21. 被引量:2
  • 8NCCN Clinical Practice Guideline in Oncology(NCCN GuidelinesTM)Cervical Cancer[EB/OL]. (2012-10-15)[2010-11-10]Ed1, 2012. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  • 9冯世莲,申艳霞.奥平栓的作用机制及其在妇产科的临床应用[J].中国自然医学杂志,2003,5(4):235-236. 被引量:6
  • 10岳晓燕, 刘冬青, 郭桃妮. 临床应用奥平栓92例疗效观察[J]. 实用妇产科杂志, 1998, 14(2): 112.

二级参考文献3

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部